Home > Income Statement > GUJARAT THEMIS BIOSYN

GUJARAT THEMIS BIOSYN
Revenue

    Back to Income Statement
GUJARAT THEMIS BIOSYN is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GUJARAT THEMIS BIOSYN
Please provide your vote to see the results

GUJARAT THEMIS BIOSYN Last 5 Year Revenue History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹151 Cr₹170 Cr₹148 Cr₹115 Cr₹91 Cr

What is the latest Revenue of GUJARAT THEMIS BIOSYN ?

The latest Revenue ratio of GUJARAT THEMIS BIOSYN is ₹151 Cr based on Mar2025 Standalone results.
Year Revenue
Mar2025₹151 Cr
Mar2024₹170 Cr
Mar2023₹148 Cr
Mar2022₹115 Cr
Mar2021₹91 Cr

How is Revenue of GUJARAT THEMIS BIOSYN Trending?

Years Revenue % Change
Mar2025 ₹151 Cr
-11.20
Mar2024 ₹170 Cr
14.45
Mar2023 ₹148 Cr
29.19
Mar2022 ₹115 Cr
26.82
Mar2021 ₹91 Cr -

Compare Revenue of peers of GUJARAT THEMIS BIOSYN

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GUJARAT THEMIS BIOSYN ₹4,307.7 Cr -1.6% -0.2% 19.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,704.0 Cr -0.5% 3.9% 12.1% Stock Analytics
DIVIS LABORATORIES ₹173,684.0 Cr -3.1% -0.1% 0.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹157,093.0 Cr 3.1% 6.7% 45.5% Stock Analytics
CIPLA ₹117,699.0 Cr 1.4% 4.8% -2.5% Stock Analytics
DR REDDYS LABORATORIES ₹111,792.0 Cr 0.8% 3.9% 1.5% Stock Analytics


GUJARAT THEMIS BIOSYN Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GUJARAT THEMIS BIOSYN

-1.6%

-0.2%

19.6%

SENSEX

1%

2.9%

-6.1%


You may also like the below Video Courses